Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmnovo Aktiebolag
AB
Active
Org 5567397368
Scheeletorget 1, 223 81
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2007
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharmnovo Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-1M
-2M
-3M
-3M
-3M
2020
-13M
2021
-26M
2022
-68M
2023
-25M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−2 769
−13 218
−26 409
−67 534
−24 657
Depreciation & amort.
−32
−37
−37
−32
−0
EBIT
−2 801
−13 255
−26 446
−67 566
−24 657
Net financials
842
—
−109
−1 286
404
Profit before tax
−1 959
−13 255
−26 556
−68 852
−24 253
Tax
−0
−0
−0
−0
−0
Net profit
−1 959
−13 255
−26 556
−68 852
−24 253
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 239
9 999
27 037
24 109
16 185
Equity
771
7 227
24 391
20 583
12 168
Long-term debt
49
49
44
44
44
Short-term debt
419
2 723
2 602
3 482
3 973
Total debt
468
2 772
2 646
3 526
4 017
Financial ratios
5-year trend
EBITDA margin
-2465700000.0%
This company
15.8%
Market median
-15605696303% vs market
2020
2024
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
2020
2024
Return on equity
-199.3%
This company
18.4%
Market median
-1183% vs market
2020
2024
Net profit margin
-2425300000.0%
This company
8.1%
Market median
-29941975409% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
View
PDF
More on Pharmnovo Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
